|
[1]
|
Joint Prevention and Control Mechanism of State Council. Notice on further optimizing epidemic prevention and control measures of COVID-19. 2022. http://www.gov.cn/xinwen/2022-12/07/content_5730475.htm. [2023-3-10]. (In Chinese). http://www.gov.cn/xinwen/2022-12/07/content_5730475.htm |
|
[2]
|
Chinese Center for Disease Control and Prevention. Epidemic situation of COVID-19 infection in China. 2023. https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202303/t20230304_264035.html. [2023-3-10]. (In Chinese). https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202303/t20230304_264035.html |
|
[3]
|
Huang ZY, Xu SF, Liu JC, Wu LL, Qiu J, Wang N, et al. Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death. BMC Med 2022;20(1):400. http://dx.doi.org/10.1186/s12916-022-02606-8CrossRef
|
|
[4]
|
Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med 2021;385(10):875 − 884. http://dx.doi.org/10.1056/NEJMoa2107715CrossRef
|
|
[5]
|
Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70(1):41 − 55. http://dx.doi.org/10.1093/biomet/70.1.41CrossRef
|
|
[6]
|
Wei YY, Gao WJ, Zhang LY, Wang SG, Zhan SY, Ren T, et al. Epidemiological survey of 2019-nCoV infection in staff and students in some public health schools in China. Chin J Epidemiol 2023;44(2):175 − 183. http://dx.doi.org/10.3760/cma.j.cn112338-20221231-01092 (In Chinese). CrossRef
|
|
[7]
|
Liu J, Ding F, Wu Y, Jing WZ, Yan WX, Qin CY, et al. Trends of SARS-CoV-2 infection in sentinel community-based surveillance after the optimization of prevention and control measures — China, December 2022–January 2023. China CDC Wkly 2023;5(7):159 − 164. http://dx.doi.org/10.46234/ccdcw2023.028CrossRef
|
|
[8]
|
Kang M, Yi Y, Li Y, Sun LM, Deng AP, Hu T, et al. Effectiveness of inactivated COVID-19 vaccines against illness caused by the B.1.617.2 (Delta) variant during an outbreak in Guangdong, China: a cohort study. Ann Intern Med 2022;175(4):533 − 540. http://dx.doi.org/10.7326/m21-3509CrossRef
|
|
[9]
|
Cerqueira-Silva T, Katikireddi SV, De Araujo Oliveira V, Flores-Ortiz R, Júnior JB, Paixão ES, et al. Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil. Nat Med 2022;28(4):838 − 843. http://dx.doi.org/10.1038/s41591-022-01701-wCrossRef
|
|
[10]
|
Yang ZR, Jiang YW, Li FX, Liu D, Lin TF, Zhao ZY, et al. Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials. Lancet Microbe 2023;4(4):E236 − E246. http://dx.doi.org/10.1016/s2666-5247(22)00390-1CrossRef
|